| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.59 | 6e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.45 | 0.003 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |